Programs

Dr. Hoffman is a member of the St. Jude faculty and clinical staff, with his appointment based in the Pharmaceutical Department. He has emerged as a senior leader within the St. Jude clinical staff, currently serving as the Chief Patient Safety Officer for St. Jude Children’s Research Hospital (SJCRH). Dr. Hoffman earned both his undergraduate and doctoral degrees from the Philadelphia College of Pharmacy at the University of the Sciences in Philadelphia. In 2014, he was recognized as young alumnus of the year by the University of the Sciences. He earned his MS degree at the University of Wisconsin-Madison, completed postgraduate training at the University of Wisconsin Hospital and Clinics, and is also a board certified pharmacotherapy specialist (BCPS). Dr. Hoffman was recruited to SJCRH in 2004. He has made a profound impact since joining, significantly enhancing the care that patients receive and the role that his department plays in the care of children with cancer, sickle cell, HIV, and other potentially devastating diseases. His primary interests include patient safety event detection, clinical decision support, and the clinical implementation of pharmacogenetics. Dr. Hoffman is an investigator on PG4KDS (www.stjude.org/pg4kds), which is St. Jude’s prospective clinical trial to optimize the processes required to successfully implement preemptive pharmacogenomics for “precision medicine.” In addition, he has been a member of the global Clinical Pharmacogenomics Implementation Consortium (CPIC) since its inception. Dr. Hoffman’s influence has extended well beyond clinics and inpatient units, as his many accomplishments, including teaching, professional organizational work, mentoring, and publications have impacted the care of children worldwide.